In December 2020, China promulgated the Criminal Law Amendment (XI) (刑法修正案(十一)), three articles of which concern biosecurity as well as the prevention and control of infectious diseases such as COVID-19.
Empirical studies in Chengdu Courts show that the COVID-19 pandemic prompted a widespread shift to online litigation, which has been unexpectedly popular among judges and litigants.
What has China's Supreme Court been doing during the pandemic? Judge Shen Hongyu talked about the SPC's response to COVID-19 in Nov. 2020.
Judge Shen Hongyu of China's Supreme People's Court (SPC) talked about the SPC's response to the COVID-19 pandemic in Nov. 2020, and introduced cross-border dispute resolution in the post-pandemic era.
China's First Biosecurity Law: Infectious Disease Control, Laboratory Biosafety and Biological Warfare Prevention
The Biosecurity Law (生物安全法) was promulgated on 17 Oct. 2020 and will enter into force on 15 Apr. 2021. In the post-COVID-19 age, this Law lays a foundation for setting up a legal regime of biosecurity in China.
CICC Studies Force Majeure Rules from Over 60 Jurisdictions: Chinese Courts Respond to COVID-19 Series-04
This study, commissioned by China International Commercial Courts (CICC), provides an assessment of force majeure rules in multiple jurisdictions. Seven study reports are available online.
In June 2020, China's Supreme Court issued the third COVID-19-related judicial document, addressing limitation period, force majeure as well as the trial of maritime cases and letter of credit cases.
In May 2020, China's Supreme Court issued the second COVID-19-related judicial document, addressing the issues in contract disputes, finance disputes, and bankruptcy cases.
In Apr. 2020, China's Supreme Court issued the first COVID-19-related judicial document, addressing the issues of force majeure, labor disputes, and limitation of action.
How would Chinese courts view arbitral awards where foreign tribunals reject a force majeure claim connected to the coronavirus (COVID-19) pandemic?